Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q3 EPS of ($1.54), $2.60 better than the analyst estimate of ($4.14).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.